EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas

Amélie Darlix iD, Pierre Bady iD, Jérémy Deverdun, Emmanuelle Le Bars iD, Arthur Coget, Justine Meriadec, Mathilde Carrière, Hugues Duffau iD, Monika E Hegi iD

Neuro-Oncology · 2026

DOI: 10.1093/neuonc/noaf296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2026. Verfasst von Amélie Darlix und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Institut Régional du Cancer de Montpellier, University of Montpellier, Montpellier, France. Hauptthemen laut MEDLINE: Astrocytoma, Brain Neoplasms, Oligodendroglioma, Isocitrate Dehydrogenase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Brain Tumour Charity, Swiss Cancer Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The life expectancy of patients with diffuse IDH-mutant low-grade gliomas (IDHmt LGG) ranges from 5 to over 20 years. Tumor behavior, including spontaneous growth rate, varies even within homogeneously classified subtypes of oligodendroglioma and astrocytoma. Risk-adjusted treatment strategies are needed to avoid therapy-related toxicities without compromising outcome. The spontaneous tumor volume growth rate (TVGR) serves as a prognostic marker and predicts response to therapy. Accurate prediction of TVGR through biomarkers would enable improved evidence-based risk management. Patients and Methods A cohort of 77 patients treated in Montpellier, France, for IDHmt LGG grade II (WHO 2016) (29 oligodendrogliomas and 48 astrocytomas) was constituted (age >18 years; MRI scans, frozen tumor tissue). The DNA methylome (Illumina, EPIC array) and transcriptome (RNAseq) were established. TVGR was determined based on serial MRIs collected over the “watch & wait” period before the first treatment beyond surgery. Transcriptomic and methylome data were analyzed for signatures associated with TVGR using rank-rank regression followed by preranked gene set enrichment analysis.

Results

The median TVGR was lower in IDHmt codeleted compared to non-codeleted LGG (0.241 year−1 range 0.082-0.366 vs. 0.424 year−1 range 0.264-0.609, P < .001). In codeleted IDHmt LGG, TVGR was associated with upregulated gene signatures for neuronal systems, synaptic activity, and activation of repressed or poised signatures of neural progenitor cells, while the TVGR in non-codeleted IDHmt LGG was dominated by upregulated proliferation-related signatures, including DNA replication and repair.

Conclusion

Spontaneous TVGR of codeleted and non-codeleted IDHmt LGG involves distinct biological processes, suggesting possible differences in response to therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytomaBrain NeoplasmsOligodendrogliomaIsocitrate DehydrogenaseBiomarkers, TumorMutationHumansMaleFemaleMiddle AgedAdultDNA MethylationPrognosisYoung AdultAgedFollow-Up StudiesNeoplasm GradingTranscriptome

Stichwörter der Autor:innen

IDHmt diffuse LGG WHO grade IImolecular signaturestumor volume growth rate

Substanzen

Isocitrate DehydrogenaseBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Oncology, Institut Régional du Cancer de Montpellier, University of Montpellier, Montpellier, France.
  • Institute of Functional Genomics (IGF), University of Montpellier, CNRS, INSERM, Montpellier, France.
  • Neuroscience Research Center and Service of Neurosurgery, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Translational Data Science Facility, Swiss Institute of Bioinformatics, AGORA Cancer Research Centre, Lausanne, Switzerland.
  • I2FH, Institut d'Imagerie Fonctionnelle Humaine, Department of Neuroradiology, Montpellier University Medical Center, Montpellier, France.
  • Department of Neuroradiology, Gui de Chauliac Hospital, Montpellier University Medical Center, Montpellier, France.

ORCID-Profile: Amélie Darlix, Pierre Bady, Emmanuelle Le Bars, Hugues Duffau, Monika E Hegi

Förderung

  • The Brain Tumour Charity
  • Swiss Cancer Research Foundation

Zitieren

APA

Darlix, A., Bady, P., Deverdun, J., Bars, E. L., Coget, A., Meriadec, J., Carrière, M., Duffau, H., & Hegi, M. E. (2026). Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf296

Vancouver

Darlix A, Bady P, Deverdun J, Bars EL, Coget A, Meriadec J, et al. Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas. Neuro-Oncology. 2026. doi:10.1093/neuonc/noaf296

BibTeX
@article{Darlix2026,
  author = {Darlix, Amélie and Bady, Pierre and Deverdun, Jérémy and Bars, Emmanuelle Le and Coget, Arthur and Meriadec, Justine and Carrière, Mathilde and Duffau, Hugues and Hegi, Monika E},
  title = {Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas},
  journal = {Neuro-Oncology},
  year = {2026},
  doi = {10.1093/neuonc/noaf296}
}
Kostenlos starten →